Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-01, Stock:JNJ, The news for the past five days is as follows:
2021-02-22: NEWS1: UPDATE 2-Pfizer to ship 13 mln COVID-19 vaccine doses per week to U.S. by mid-March, says executive.NEWS2: Coronavirus update: US surpasses 500K deaths; FDA addresses variants and vaccines.NEWS3: U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&J’s one-dose vaccine.NEWS4: Why Novavax Stock Sank Today.NEWS5: U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine.NEWS6: Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine.NEWS7: FDA committee to review J&J's COVID-19 vaccine candidate on Thursday.NEWS8: Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback.NEWS9: Sanofi, GSK Restart Trials on Covid-19 Vaccine After Delay.
2021-02-23: NEWS1: Big Pharma Short Percentage Is Below Overall Market.NEWS2: COVID-19 vaccine manufacturing is improving, executives tell Congress.NEWS3: Doctor: We could optimistically reach herd immunity by ‘late summer’.NEWS4: Vaccine Makers Promise More Supply as FDA Clears Path for Faster Updates.NEWS5: Lyft partners with CVS to increase accessibility of the COVID-19 vaccine.NEWS6: J&J to Deliver 20 Million Doses of COVID Vaccine to U.S. By End of March.NEWS7: UPDATE 2-S.Africa says J&J, Pfizer, Moderna vaccines those for "immediate use".NEWS8: J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March.NEWS9: FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants.NEWS10: What Are Johnson & Johnson's Chances of Success With Its COVID Vaccine?.NEWS11: Cape Town is testing a Covid-19 vaccine designed to protect against new variants.NEWS12: Johnson & Johnson sets aside almost $4 billion for talc verdict, filing shows.NEWS13: Johnson & Johnson sets aside almost $4 bln for talc verdict, filing shows.
2021-02-24: NEWS1: REFILE-US STOCKS-Wall Street finishes up as Fed's Powell soothes inflation fears.NEWS2: Stock Market Today: Dow Jones Cruises to Record Altitude.NEWS3: Johnson & Johnson Nabs FDA Endorsement For Covid Shot Ahead Of Key Meeting.NEWS4: Dow Jones Rises, Hits New High After Fed Chairman Powell's Comments; This Chip Stock Breaks Out.NEWS5: US STOCKS-Wall Street closes higher as Fed's Powell soothes inflation fears.NEWS6: J&J Grabs FDA Endorsement For Covid Vaccine; Is JNJ Stock A Buy?.NEWS7: Dow Jones Rallies 300 Points On Powell Comments; Boeing, Disney Stocks Soar.NEWS8: UPDATE 2-White House to roll out J&J vaccine doses next week, pending authorization.NEWS9: Charlie Munger, Q4 GDP, Disney: 3 Things to Watch.NEWS10: Johnson & Johnson Nabs FDA Endorsement For Covid Shot Ahead Of Key Meeting.NEWS11: Johnson & Johnson's Single-Dose Coronavirus Shot Gets Favorable FDA Review Ahead Of Adcom Meeting.NEWS12: FDA Brings J&J Vaccine a Step Closer to Authorization.NEWS13: J&J’s single-shot COVID-19 vaccine is safe and effective, says FDA.NEWS14: Top 15 Pharmaceutical Companies With Highest R&D Spending.NEWS15: J&J’s one-shot COVID-19 vaccine nears authorization as FDA has no ‘specific safety concerns’.NEWS16: J&J’s COVID-19 vaccine nears authorization as FDA says it has no ‘specific safety concerns’.NEWS17: UPDATE 3-Johnson & Johnson's one-dose vaccine closes in on U.S. approval.NEWS18: Johnson & Johnson's one-dose vaccine closes in on U.S. approval.NEWS19: Johnson & Johnson's one-shot COVID-19 vaccine effective and safe- FDA staff.NEWS20: Jim Cramer on Dave Portnoy, Cathie Wood,  Johnson & Johnson, Tesla, Stock Market Wednesday.NEWS21: 2 Reasons the FDA Is Likely to Authorize the Johnson & Johnson Vaccine Next Week.NEWS22: LIVE: Jim Cramer on Dave Portnoy, Cathie Wood,  Johnson & Johnson, Tesla, Stock Market Wednesday.NEWS23: Johnson & Johnson Will Deliver 20 Million Doses of COVID Vaccine to U.S. By End of March.NEWS24: Pfizer, Moderna, J&J Pledge To Make 240M COVID-19 Vaccine Doses Available In US By March-End.NEWS25: Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing.NEWS26: J&J vaccine performs well against variants in boost for Covid battle.NEWS27: Johnson & Johnson’s Covid-19 vaccine is effective, FDA report confirms.
2021-02-25: NEWS1: Dr. Elizabeth Clayborne on her outlook for the COVID-19 vaccination timeline.NEWS2: ‘Covid-19 has been the perfect storm for adversaries’ in cybersecurity industry: CrowdStrike.NEWS3: Vaccine makers defend patent rights, oppose export bans before EU lawmakers.NEWS4: Doctor: New COVID-19 strains come from ‘robust transmission of the virus’.NEWS5: UPDATE 1-Kenya says first batch of COVID-19 vaccines to arrive in March.NEWS6: Marriott International Stock Rising As Travel Prospects Improve Amid Vaccinations.NEWS7: Dow Jones Today, Stocks Mixed After GDP, Jobs Data; Nvidia, Tesla Slump; Twitter Rallies; Bond Yields Rise.NEWS8: UPDATE 1-Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use - regulator.NEWS9: UPDATE 1-South Africa aims to vaccinate 1.1 mln by end of March.NEWS10: Dow Jones Today, Futures Mixed Ahead Of GDP, Jobs Data; Tesla Slumps, Li Auto Rallies; Bond Yields Rise.NEWS11: FOCUS-Wanted: More high-tech manufacturing space for a global vaccine push.NEWS12: 4 Robinhood Stocks Billionaires Can't Stop Buying.NEWS13: Morning Bell With Jim Cramer: Buy Chipotle Over McDonald's.NEWS14: Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia.NEWS15: GLOBAL MARKETS-Asian shares jump after Powell nixes rate hike fears.NEWS16: GLOBAL Market-Asian open higher as Fed's Powell nixes inflation fears.NEWS17: Africa will pay more for Russian Covid vaccine than ‘western’ jabs.
2021-02-26: NEWS1: FDA tells J&J it's working on an emergency authorization for its COVID-19 vaccine.NEWS2: FDA Committee Votes in Favor Of Johnson &  Johnson’s Covid-19 Vaccine.NEWS3: Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee.NEWS4: FDA Panel Unanimously Endorses J&J's Covid Vaccine For Emergency Use.NEWS5: FDA committee votes unanimously, says benefits of J&J's COVID-19 vaccine outweigh the risks.NEWS6: J&J single-dose COVID-19 vaccine gets green light from FDA.NEWS7: Dow Jones Falls While Nasdaq Recovers Some Losses; These Dow Stocks Trade Near Buy Zones.NEWS8: FDA Panel Discusses J&J's Covid Vaccine: What You Need To Know.NEWS9: Dow Jones Falls While Nasdaq, S&P 500 Recover Some Losses; These Dow Stocks Trade Near Buy Zones.NEWS10: Doctor: JNJ’s single-dose vaccine ‘has the potential to be a game changer’.NEWS11: Dow Jones Dips, Nasdaq Rallies As Tech Stocks Rebound; House To Vote On Stimulus Bill.NEWS12: Johnson & Johnson One-Shot Vaccine Wins Advisory Panel OK.NEWS13: J&J says 2 people had severe allergic reactions after COVID-19 shot.NEWS14: Vaccine Stocks Drop With J&J Set to Release Third U.S. Shot.NEWS15: Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine.NEWS16: Medically Necessary: Delaying Second Doses Would Reshape The Vaccine Supply Chain.NEWS17: The Great Promise of a One-Dose Vaccine.NEWS18: UPDATE 5-U.S. near authorization of Johnson & Johnson COVID-19 vaccine.NEWS19: FDA Panel To Discuss J&J's Covid Vaccine: What You Need To Know.NEWS20: An FDA Committee Meets Today to Discuss Johnson & Johnson’s Vaccine. Here’s What to Expect..NEWS21: Bitcoin Has Tumbled More Than 20%. What to Make of Its Bear Market..NEWS22: Novavax Surges Again On Vaccine Supply Deal; Is NVAX Stock A Buy?.NEWS23: Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg.NEWS24: Coronavirus tally: Global cases of COVID-19 top 113 million and U.S. death toll atop 508,000.NEWS25: FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected.NEWS26: Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains?.NEWS27: FOCUS-AstraZeneca, Sputnik vaccines face hurdles if COVID shots become annual affair.NEWS28: FDA advisory panel endorses Johnson & Johnson’s Covid-19 vaccine.NEWS29: FDA advisory panel reviews Johnson & Johnson’s Covid-19 vaccine.

Answer: Rise